IBK Keeps 4 Million Won Target on SK hynix, Citing Undervaluation
IBK Investment & Securities maintains a buy rating and 4 million won target price for SK hynix (000660.KS), citing undervaluation and strong demand for memory chips. The firm forecasts Q3 2026 revenue of 95.8 trillion won and operating profit of 75.1 trillion won, with high profitability. SK hynix plans to return over 50% of free cash flow to shareholders, with potential additional buybacks.
How this was made

The 30-second read
Why it matters
The upgrade provides a fresh catalyst for the stock, suggesting a near‑term rally as investors adjust valuations to the higher target and improved margin outlook.
Market read
The new target and forecasts could drive buying interest in SK hynix and influence sentiment toward the broader memory‑chip sector.
What to watch
Potential currency headwinds from a stronger won could erode margin gains despite higher prices.
Background
IBK Investment & Securities issued a new research note on 7 Oct 2026, keeping its buy rating on SK hynix and setting a 4 million won target price, while updating Q3 2026 revenue, operating profit, and DRAM price assumptions.
Ticker impact
IBK Investment & Securities maintains a buy rating and a 4 million won price target for SK hynix, providing fresh Q3 2026 revenue and profit forecasts and raising its DRAM price outlook.
likely upward pressure as investors price in the new target and improved margin outlook
The report is the first public disclosure of IBK's revised forecasts and target price, offering a concrete catalyst for short‑term buying.
Market effects
Positive outlook for DRAM pricing may benefit other memory manufacturers and related AI‑chip suppliers.
Strengthens sentiment toward South Korean semiconductor stocks.
Reinforces broader AI‑driven demand narrative for memory chips worldwide.
Counterpoint
If DRAM supply constraints ease faster than expected, the price uplift could be limited, tempering upside.
Key entities
- companySK hynix
South Korean memory chip maker (ticker 000660.KS).
- analystIBK Investment & Securities
Korean brokerage that issued the research note and price target.



